MBP metabolic pharmaceuticals limited

why the sell-off?, page-61

  1. 146 Posts.
    re: why the cheap prices Not many companies complete Phase III successfully, yiou say. But look at PXS. This company has completed phase III for one product and just raised more money for phase III of another product.

    Yet it drifts at 77c.
    Market cap of $80.6M, with cash of $35M+.
    I.e technologuy is valued at only at $45-$50M.
    That is so cheap for a coy completed phase III successfully, and with another going into phase III.

    Compare this company with MBP which has a market cap of $482M!!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.